Amfepramon
Amfepramon Brand names, Amfepramon Analogs
- Adiposon
- Amfepramon
- Amfepramone
- Amfepramone HCL
- Amfepramone Hydrochloride
- Amfepramonum [INN-Latin]
- Amphepramon
- Amphepramone
- Amphepramonum hydrochloride
- Anfamon
- Anfepramona [INN-Spanish]
- Anorex
- Cegramine
- DEA No. 1610
- Danylen
- Derfon
- Diethylpropion HCL
- Diethylpropion Hydrochloride
- Diethylpropione
- Diethylpropione hydrochloride
- Dobesin
- Frekentine
- Keramik
- Keramin
- Magrene
- Moderatan
- Modulor
- Neobes
- Nopropiophenone
- Obesitex
- Parabolin
- Prefamone
- Regenon
- Regenon hydrochloride
- Reginon
- Silutin
- Tenuate
- Tenuate Dospan
- Tenuate hydrochloride
- Tepanil
- Tepanil Ten-tab
- Tylinal
- alpha-Benzoyltriethylamine
- alpha-Diethylaminopropiophenone
Amfepramon Brand Names Mixture
- No information avaliable
Amfepramon Chemical_Formula
C13H19NO
Amfepramon RX_link
http://www.rxlist.com/cgi/generic3/diethprop.htm
Amfepramon fda sheet
Amfepramon msds (material safety sheet)
Amfepramon Synthesis Reference
No information avaliable
Amfepramon Molecular Weight
205.296 g/mol
Amfepramon Melting Point
No information avaliable
Amfepramon H2O Solubility
No information avaliable
Amfepramon State
No information avaliable
Amfepramon LogP
2.951
Amfepramon Dosage Forms
25 mg tablets and 75 mg controlled-release tablets.
Amfepramon Indication
Used in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction.
Amfepramon Pharmacology
Diethylpropion is a sympathomimetic stimulant drug marketed as an appetite suppressant. Chemically, it is the N,N-diethyl analog of cathinone. Its mechanism of action is similar to other appetite suppressants such as sibutramine, phentermine and dextroamphetamine.
Amfepramon Absorption
Diethylpropion is rapidly absorbed from the GI tract after oral administration.
Amfepramon side effects and Toxicity
The reported oral LD50 for mice is 600 mg/kg, for rats is 250 mg/kg and for dogs is 225 mg/kg. Manifestation of acute overdosage include restlessness, tremor, hyperreflexia, rapid respiration, confusion, assaultiveness, hallucinations, and panic states.
Amfepramon Patient Information
No information avaliable
Amfepramon Organisms Affected
Humans and other mammals
